{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260807011647/en/Scholar-Rock-Announces-FDA-Review-of-Apitegromab-Biologics-License-Application-BLA-for-Spinal-Muscular-Atrophy-SMA-to-Progress-with-Second-Fill-Finish-Facility-Approval-Decision-Anticipated-by-September-30-2026-Action-Date", "message": "News view counter 870746 successfully enlarged"}